Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (6): 602-607.DOI: 10.3969/j.issn.1673-8640.2024.06.016
Previous Articles Next Articles
Received:
2023-07-13
Revised:
2023-11-06
Online:
2024-06-30
Published:
2024-07-08
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.06.016
魏氏法 | A方法 | B方法 | |||
---|---|---|---|---|---|
≤20 mm | >20 mm | ≤20 mm | >20 mm | ||
≤20 mm | 94 | 42 | 120 | 16 | |
>20 mm | 4 | 66 | 4 | 66 | |
χ2值 | 11.010 | 0.127 | |||
P值 | <0.001 | 0.721 |
魏氏法 | A方法 | B方法 | |||
---|---|---|---|---|---|
≤20 mm | >20 mm | ≤20 mm | >20 mm | ||
≤20 mm | 94 | 42 | 120 | 16 | |
>20 mm | 4 | 66 | 4 | 66 | |
χ2值 | 11.010 | 0.127 | |||
P值 | <0.001 | 0.721 |
组别 | 例数 | 魏氏法ESR/mm | A方法 | B方法 | ||||
---|---|---|---|---|---|---|---|---|
ESR/mm | P值 | ESR/mm | P值 | |||||
低HCT组 | 157 | 34.0(16.0~64.0) | 33.0(16.0~61.0) | 0.608 | 29.5(16.8~52.4) | 0.012 | ||
正常HCT组 | 220 | 11.0(6.0~25.3) | 18.0(8.0~31.0) | <0.001 | 11.1(6.6~23.6) | 0.066 | ||
高HCT组 | 25 | 5.0(2.0~8.0) | 15.0(7.0~25.0) | <0.001 | 3.6(2.3~10.1) | 0.394 |
组别 | 例数 | 魏氏法ESR/mm | A方法 | B方法 | ||||
---|---|---|---|---|---|---|---|---|
ESR/mm | P值 | ESR/mm | P值 | |||||
低HCT组 | 157 | 34.0(16.0~64.0) | 33.0(16.0~61.0) | 0.608 | 29.5(16.8~52.4) | 0.012 | ||
正常HCT组 | 220 | 11.0(6.0~25.3) | 18.0(8.0~31.0) | <0.001 | 11.1(6.6~23.6) | 0.066 | ||
高HCT组 | 25 | 5.0(2.0~8.0) | 15.0(7.0~25.0) | <0.001 | 3.6(2.3~10.1) | 0.394 |
[1] |
RAMSAY E S, LERMAN M A. How to use the erythrocyte sedimentation rate in paediatrics[J]. Arch Dis Child Educ Pract Ed, 2015, 100(1):30-36.
DOI PMID |
[2] |
KRATZ A, PLEBANI M, PENG M, et al. ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate[J]. Int J Lab Hematol, 2017, 39(5):448-457.
DOI PMID |
[3] |
Recommendation of measurement of erythrocyte sedimentation rate of human blood[J]. Am J Clin Pathol, 1977, 68(4):505-507.
PMID |
[4] | International Council for Standardization in HaematologyExpert Panel on Blood Rheology. ICSH recommendations for measurement of erythrocyte sedimentation rate[J]. J Clin Pathol, 1993, 46(3):198-203. |
[5] |
JOU J M, LEWIS S M, BRIGGS C, et al. ICSH review of the measurement of the erythocyte sedimentation rate[J]. Int J Lab Hematol, 2011, 33(2):125-132.
DOI PMID |
[6] | MOSLEHI S, RABIEI N, SOLTANIAN A R, et al. Application of machine learning models based on decision trees in classifying the factors affecting mortality of COVID-19 patients in Hamadan,Iran[J]. BMC Med Inform Decis Mak, 2022, 22(1):192. |
[7] | 叶方, 黄淑明, 叶积飞, 等. TNF-α与ESR和IL-6对慢性骨髓炎的诊断价值[J]. 中华医院感染学杂志, 2021, 31(3):439-443. |
[8] | BRUERA S, VENTURA M J, AGARWAL S K, et al. The utility of erythrocyte sedimentation rate,C-reactive protein,and procalcitonin in detecting infections in patients with systemic lupus erythematosus:a systematic review[J]. Lupus, 2022, 31(10):1163-1174. |
[9] | YING P, LU T, XU Y, et al. Preoperative erythrocyte sedimentation rate in patients with rheumatoid arthritis predicts deep vein thrombosis following total knee arthroplasty[J]. Clin Hemorheol Microcirc, 2022, 81(1):23-31. |
[10] | BETRAINS A, BOECKXSTAENS L, VAN LAERE K, et al. Clinical implications of fever at diagnosis in polymyalgia rheumatica:an age- and sex-matched case control study of 120 patients[J]. Clin Exp Rheumatol, 2022, 40(1):193-194. |
[11] | 田鹏鹏, 朱丽莎, 马青, 等. 红细胞压积与年龄以及红细胞沉降率的关系[J]. 国际检验医学杂志, 2017, 38(2):209-210. |
[12] | 王晓欧, 陈小剑, 舒旷怡. ALIFAX-TEST1全自动化血沉仪器性能的分析[J]. 现代实用医学, 2012, 24(12):1370-1371. |
[13] | 陈显秋, 曲林琳, 王学军, 等. 性能评价、方法学评价及参考区间验证在ALIFAX血沉检测质量保证中的应用[J]. 中国实验诊断学, 2015, 19(12):2105-2108. |
[14] | 徐佳, 毛镭篥, 陈倩, 等. 毛细显微成像法测定红细胞沉降率的临床性能研究[J]. 中国卫生检验杂志, 2017, 27(1):14-17. |
[15] |
徐黎明, 王志成, 蔡枫. TEST1自动血沉仪的应用评估以及上海地区健康人群红细胞沉降率参考区间的建立[J]. 检验医学, 2017, 32(3):202-207.
DOI |
[16] | 任真, 芮刚, 王琳, 等. ALIFAX Test1血沉仪性能分析及临床应用价值验证[J]. 临床检验杂志, 2019, 37(7):550-552. |
[17] | SONMEZ C, DOGAN O C, KAYMAK A O, et al. Test-1 analyzer and conventional Westergren method for erythrocyte sedimentation rate:a comparative study between two laboratories[J]. J Clin Lab Anal, 2018, 32(5):e22384. |
[18] |
PIERI M, PIGNALOSA S, PERRONE M A, et al. Evaluation of the diesse cube 30 touch erythrocyte sedimentation method in comparison with alifax test 1 and the manual Westergren gold standard method[J]. Scand J Clin Lab Invest, 2021, 81(3):181-186.
DOI PMID |
[19] | ČIČAK H, ŠONJIĆ P, ŠIMUNDIĆ A M. Verification of automatic analysers Roller 20PN and iSED for measuring erythrocyte sedimentation rate[J]. Biochem Med(Zagreb), 2022, 32(1):010708. |
[20] |
HARDEMAN M R, LEVITUS M, PELLICCIA A, et al. Test 1 analyser for determination of ESR. 2. Experimental evaluation and comparison with RBC aggregometry[J]. Scand J Clin Lab Invest, 2010, 70(1):26-32.
DOI PMID |
[21] |
HARDEMAN M R, LEVITUS M, PELLICCIA A, et al. Test 1 analyser for determination of ESR. 1. Practical evaluation and comparison with the Westergren technique[J]. Scand J Clin Lab Invest, 2010, 70(1):21-25.
DOI PMID |
[22] | HIGUCHI M, WATANABE N. A rapid and accurate method for estimating the erythrocyte sedimentation rate using a hematocrit-corrected optical aggregation index[J]. PLoS One, 2022, 17(7):e0270977. |
[1] | ZHOU Ruiling, ZHANG Xinyu, REN Xiaoling, ZHANG Wen, FAN Changzheng, ZHANG Qiong. Relationship between uric acid/creatinine ratio and neutrophil/lymphocyte ratio and hypoxemia in patients with acute exacerbation of chronic obstructive pulmonary disease [J]. Laboratory Medicine, 2024, 39(5): 474-479. |
[2] | LI Kejing, WANG Lin, YANG Ning. Relationship between NLR,TGF-β1 and Cav-1 levels and bleeding risk after mechanical thrombectomy for acute intracranial artery occlusion in elders [J]. Laboratory Medicine, 2024, 39(5): 480-484. |
[3] | LIU Lin, WANG Tiankai, QIN Kangchunfeng, DING Ning. Correlations between monocyte-to-lymphocyte ratio with coronary heart disease and the extent of coronary atherosclerosis [J]. Laboratory Medicine, 2024, 39(5): 485-490. |
[4] | WANG Xuexing, CHEN Chunmei, HE Yuan, CHU Jie, WEI Chunmei. Roles of thromboelastography and coagulation index in predicting venous thromboembolism in patients with tumors [J]. Laboratory Medicine, 2024, 39(5): 491-496. |
[5] | XIONG Tianhui, CHAI Kening, XIA Wei, QU Linlin. Research progress of rivaroxaban causing changes in platelet count and function [J]. Laboratory Medicine, 2024, 39(5): 504-509. |
[6] | . [J]. Laboratory Medicine, 2024, 39(5): 513-516. |
[7] | HUANG Lei, TANG Wenjia, ZHOU Yan, ZHOU Jiaye, ZHANG Chunyan, YANG Jing, WANG Beili, PAN Baishen, GUO wei. Prognosis of RDW-SD and RDW-CV in breast cancer patients with lymphatic metastasis [J]. Laboratory Medicine, 2024, 39(4): 376-381. |
[8] | . [J]. Laboratory Medicine, 2024, 39(1): 68-70. |
[9] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
[10] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
[11] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
[12] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
[13] | . [J]. Laboratory Medicine, 2023, 38(9): 901-904. |
[14] | . [J]. Laboratory Medicine, 2023, 38(9): 905-908. |
[15] | CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||